The History of NxStage Medical
2016
Reports full-year revenue increases to $366 million
$366 M
2015
8,000 patients
on NxStage® System One™
2014
Reports full-year revenue increases to $301.5 million
$301.5 M
NxStage begins to expand number of NxStage Kidney Care Centers across the United States
2014
System One
receives clearance for home nocturnal haemodialysis therapy
December 2014
2013
JUL
NxStage opens first Kidney Care dialysis center
Battelle teams wins DARPA contract to build medical device
to treat sepsis
2013
APR
NxStage moves to direct sales in Canada and UK
FDA clearance for new high flow capabilities for System One S
FEB
CE mark approval for nocturnal home haemodialysis
CE mark approval for high flow capabilities for System One S
2012
OCT
Grand opening of new NxStage Headquarters
2011
JUL
Distribution agreement with Theradial in Orvault, France.
MAY
Distribution agreement with Regional Health Care Group in Rosebery, Australia.
2011
FEB
NxStage announces over 5,000 patients using the System One for home haemodialysis
2010
JUL
Distribution agreement with Spindial in Lumignano, Italy.
MAR
Distribution agreement with Dirinco in Oss, The Netherlands.
FEB
Distribution agreement with Nordic MedCom in
Boras, Sweden.
2009
Strategic business alliance with Ashai KASEI
2007
OCT
NxStage completes its acquisition of Medisystems®
2006
OCT
First patients enrolled in the Freedom Study
2005
OCT
NxStage goes public
JUN
System One receives clearance for home haemodialysis use
2004
System One receives CE clearance for home haemodialysis use
1998